Success Metrics

Clinical Success Rate
72.7%

Based on 8 completed trials

Completion Rate
73%(8/11)
Active Trials
0(0%)
Results Posted
38%(3 trials)
Terminated
3(27%)

Phase Distribution

Ph phase_1
6
55%
Ph phase_2
5
45%

Phase Distribution

6

Early Stage

5

Mid Stage

0

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
6(54.5%)
Phase 2Efficacy & side effects
5(45.5%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

72.7%

8 of 11 finished

Non-Completion Rate

27.3%

3 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(8)
Terminated(3)

Detailed Status

Completed8
Terminated3

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
72.7%
Most Advanced
Phase 2

Trials by Phase

Phase 16 (54.5%)
Phase 25 (45.5%)

Trials by Status

completed873%
terminated327%

Recent Activity

0 active trials
Showing 5 of 11
terminatedphase_1

ABT-751 With Chemotherapy for Relapsed Pediatric ALL

NCT00439296
completedphase_2

ABT-751 in Treating Children With Neuroblastoma That Has Relapsed or Not Responded to Previous Treatment

NCT00436852
completedphase_1

Study of ABT-751 in Patients With Refractory Hematologic Malignancies

NCT00047489
completedphase_1

A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer

NCT00297089
terminatedphase_1

ABT-751 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

NCT00471718
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT00439296Phase 1

ABT-751 With Chemotherapy for Relapsed Pediatric ALL

Terminated
NCT00436852Phase 2

ABT-751 in Treating Children With Neuroblastoma That Has Relapsed or Not Responded to Previous Treatment

Completed
NCT00047489Phase 1

Study of ABT-751 in Patients With Refractory Hematologic Malignancies

Completed
NCT00297089Phase 1

A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer

Completed
NCT00471718Phase 1

ABT-751 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Terminated
NCT00036959Phase 1

ABT-751 in Treating Young Patients With Refractory Solid Tumors

Completed
NCT00354562Phase 1

A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non-Small Cell Lung Cancer

Terminated
NCT00063102Phase 2

A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol or Taxotere) Therapy.

Completed
NCT00073138Phase 2

A Study of ABT-751 in Patients With Colorectal Cancer

Completed
NCT00073112Phase 2

A Study of ABT-751 in Patients With Renal Cell Cancer

Completed
NCT00073151Phase 2

A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer

Completed

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11